about
The ins and outs of RND efflux pumps in Escherichia colipH Modulation of efflux pump activity of multi-drug resistant Escherichia coli: protection during its passage and eventual colonization of the colonIon Channel Blockers as Antimicrobial Agents, Efflux Inhibitors, and Enhancers of Macrophage Killing Activity against Drug Resistant Mycobacterium tuberculosisAntibiotic stress, genetic response and altered permeability of E. coli.Demonstration of intrinsic efflux activity of Escherichia coli K-12 AG100 by an automated ethidium bromide method.Fluorometric determination of ethidium bromide efflux kinetics in Escherichia coli.Exploring the contribution of efflux on the resistance to fluoroquinolones in clinical isolates of Staphylococcus aureusEnhanced killing of intracellular multidrug-resistant Mycobacterium tuberculosis by compounds that affect the activity of efflux pumps.Phenothiazines as anti-multi-drug resistant tubercular agents.Potential role of non-antibiotics (helper compounds) in the treatment of multidrug-resistant Gram-negative infections: mechanisms for their direct and indirect activities.The TB laboratory of the future: macrophage-based selection of XDR-TB therapeutics.Evidence of metabolic switching and implications for food safety from the phenome(s) of Salmonella enterica serovar Typhimurium DT104 cultured at selected points across the pork production food chain.Multidrug-Resistant Escherichia coli in Bovine Animals, EuropePromising therapy of XDR-TB/MDR-TB with thioridazine an inhibitor of bacterial efflux pumps.Molecular tools for rapid identification and novel effective therapy against MDRTB/XDRTB infections.Targeting the human macrophage with combinations of drugs and inhibitors of Ca2+ and K+ transport to enhance the killing of intracellular multi-drug resistant Mycobacterium tuberculosis (MDR-TB)--a novel, patentable approach to limit the emergence oInhibitors of mycobacterial efflux pumps as potential boosters for anti-tubercular drugs.A Simple Method for Assessment of MDR Bacteria for Over-Expressed Efflux Pumps.Salmonella-host interactions - modulation of the host innate immune system.Mechanisms of fluoroquinolone resistance in Escherichia coli isolates from food-producing animals.In vitro and in vivo biological characterization of the anti-proliferative potential of a cyclic trinuclear organotin(iv) complex.Characterization of antimicrobial resistance in Salmonella enterica food and animal isolates from Colombia: identification of a qnrB19-mediated quinolone resistance marker in two novel serovars.Efflux-mediated response of Staphylococcus aureus exposed to ethidium bromide.Phenothiazines alter resistance of methicillin-resistant strains of Staphylococcus aureus (MRSA) to oxacillin in vitro.Prolonged exposure of methicillin-resistant Staphylococcus aureus (MRSA) COL strain to increasing concentrations of oxacillin results in a multidrug-resistant phenotype.Identification of efflux-mediated multi-drug resistance in bacterial clinical isolates by two simple methods.SILA 421, an inhibitor of efflux pumps of cancer cells, enhances the killing of intracellular extensively drug-resistant tuberculosis (XDR-TB).In vitro and ex vivo activity of thioridazine derivatives against Mycobacterium tuberculosis.Inhibition of the Carpobrotus edulis methanol extract on the growth of phagocytosed multidrug-resistant Mycobacterium tuberculosis and methicillin-resistant Staphylococcus aureus.Clinical concentrations of thioridazine kill intracellular multidrug-resistant Mycobacterium tuberculosis.Gamma delta T cell responses associated with the development of tuberculosis in health care workers.Increased Interleukin-4 production by CD8 and gammadelta T cells in health-care workers is associated with the subsequent development of active tuberculosis.Genetic response of Salmonella enterica serotype Enteritidis to thioridazine rendering the organism resistant to the agent.Evaluation of efflux activity of bacteria by a semi-automated fluorometric system.Inducement and reversal of tetracycline resistance in Escherichia coli K-12 and expression of proton gradient-dependent multidrug efflux pump genes.Comparative Genotypic and Phenotypic Analysis of Cronobacter Species Cultured from Four Powdered Infant Formula Production Facilities: Indication of Pathoadaptation along the Food Chain.Complete Genome Sequence of Salmonella enterica Serovar Agona Pulsed-Field Type SAGOXB.0066, Cause of a 2008 Pan-European OutbreakCorrection: Exploring the contribution of efflux on the resistance to fluoroquinolones in clinical isolates of Staphylococcus aureus.Phenotypic characterization of Salmonella isolated from food production environments associated with low-water activity foods.Acid environments affect biofilm formation and gene expression in isolates of Salmonella enterica Typhimurium DT104.
P50
Q28084596-93720CBE-A4D7-482A-BA87-71D5F44D357CQ28475954-A8044412-2503-479B-89BE-157E5812002DQ28550401-CCC9616B-BD17-4DB3-924E-1450CF00285BQ33281751-1489412A-8CCD-4909-B912-F56C07F6DA1EQ33324044-F17924DE-83B9-4B18-A0FC-B587C812D396Q33511013-F3D9B152-75FF-470D-8F5F-3C265378178AQ34059927-9C998386-7F6A-4A53-9759-280423D9B895Q36705837-BAC6FC88-E97E-4E80-BCB7-AC92F2E0C129Q36952454-F637F538-907A-41A1-BB85-F13E6A920BFCQ37052368-DBE304F3-5945-4537-B4C1-BCDE21BC8883Q37119027-23C760BB-FF42-442F-A6AB-3EEE83E5D9DEQ37123609-40D77DE2-5479-4D9E-9EC5-BB04888B18A2Q37196241-F75628C1-BF88-4225-BAD0-0946D6008467Q37264683-C90DA330-D130-48BF-9155-8F387702F2D1Q37727181-2CB5113E-9C70-47E0-AF09-6DEC9A09610CQ37868593-ACC91DCD-14DF-4BE1-BA38-5CC9D5F1615FQ38056146-CFCFD723-2D05-426B-B092-B98A5D6647BBQ38099322-25A7736D-A3FA-4342-8AF8-5F2480E7824AQ38262126-325FA95A-8F3B-4958-916F-3889DB6A634AQ38724103-F65BACC1-EF17-473D-A1D8-EAFE00DF95A5Q38796884-073BB1DE-5939-41FD-A388-D9C8D394A187Q38871710-D3A80D04-955E-4F25-9DA9-DA6B3B995002Q38955073-A9F3FE02-B0FD-443D-A7B9-867C16CE8E5EQ39148696-F8398AE0-1B75-4FEC-A0D8-9A81E92822BDQ39219776-F035F84D-172F-4235-A0A0-23018F8F5575Q39219976-24F8CD4C-4E1B-472D-B35C-385D86455436Q39219987-06B72B55-57FC-4ABF-BE7D-EC83D1D77D99Q39220012-145BAF6F-46F5-4A8F-A5D0-2F00AC0DC55FQ39220023-4105B745-FF13-451D-B96E-17011774A957Q39326462-4F96FEA7-5D0F-4198-94E1-97283409B9EBQ39326485-22218888-E9AB-4400-B285-C42834215E08Q39326494-A2569966-4CD6-4E2E-B0E7-09C5C683D1C8Q39482709-D568B523-2795-4FF6-900B-6838C73FFCA3Q39563354-6D09B31C-52A6-417D-8091-05512B2C9274Q39563388-AFF40D45-9387-4B23-9961-ECFF572C2DA9Q41287346-B32F993E-7CF5-4956-9B8C-344CC5153223Q41889154-D717A99C-69B8-4EA5-9359-A7922E42BC99Q46506425-F9FBB62F-B445-43AC-9CED-62DAE6224395Q46622904-23FE3B6E-EC72-4C58-B804-F29D42911B14Q49988256-D0168A48-5C63-4AC7-B952-82469D0058F8
P50
description
hulumtuese
@sq
researcher
@en
ricercatrice
@it
wetenschapper
@nl
հետազոտող
@hy
name
Marta Martins
@ast
Marta Martins
@en
Marta Martins
@es
Marta Martins
@nl
Marta Martins
@sl
type
label
Marta Martins
@ast
Marta Martins
@en
Marta Martins
@es
Marta Martins
@nl
Marta Martins
@sl
altLabel
Marta Martins
@en
prefLabel
Marta Martins
@ast
Marta Martins
@en
Marta Martins
@es
Marta Martins
@nl
Marta Martins
@sl
P214
P106
P21
P214
P2798
P31
P496
0000-0002-0323-2857
P734
P735
P7859
viaf-165735064